TIPE3 and breast cancer: Interestingly, blocking PI3K-AKT pathway by LY294002 largely abolished the activation of NF-κB induced by TIPE3 overexpression, suggesting that TIPE3 might activate NF-κB through AKT pathway during breast cancer development.